Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133527) titled 'Predictive Value of Neutrophil Percentage-to-Albumin Ratio for Prognosis in Patients with Acute Respiratory Distress Syndrome' on Sept. 29.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Tongji Hospital
Condition:
Acute Respiratory Distress Syndrome
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: ARDS group:360;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345479
Published by HT Digital Content Services with permission from Health Daily Digest....